BioGaia AB (publ)

SSE:BIOG-B.ST

124.4 (SEK) • At close February 20, 2024
Bedrijfsnaam BioGaia AB (publ)
Symbool BIOG-B.ST
Munteenheid SEK
Prijs 124.4
Beurswaarde 12,101,507,600
Dividendpercentage 3.72%
52-weken bereik 87.95 - 128.7
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Isabelle Valerie Ghislaine Ducellier
Website https://www.biogaia.com

An error occurred while fetching data.

Over BioGaia AB (publ)

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The

Vergelijkbare Aandelen

Synsam AB (publ) logo

Synsam AB (publ)

SYNSAM.ST

45.15 SEK

Camurus AB (publ) logo

Camurus AB (publ)

CAMX.ST

440 SEK

CellaVision AB (publ) logo

CellaVision AB (publ)

CEVI.ST

257 SEK

BICO Group AB (publ) logo

BICO Group AB (publ)

BICO.ST

45.4 SEK

Surgical Science Sweden AB (publ) logo

Surgical Science Sweden AB (publ)

SUS.ST

179.1 SEK

Xvivo Perfusion AB (publ) logo

Xvivo Perfusion AB (publ)

XVIVO.ST

282 SEK

BioArctic AB (publ) logo

BioArctic AB (publ)

BIOA-B.ST

227.8 SEK

Biotage AB (publ) logo

Biotage AB (publ)

BIOT.ST

184.3 SEK

Swedencare AB (publ) logo

Swedencare AB (publ)

SECARE.ST

60.34 SEK

Calliditas Therapeutics AB (publ) logo

Calliditas Therapeutics AB (publ)

CALTX.ST

107.8 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)